).
Over the past few decades, the field of acute ischemic stroke (AIS) has made landmark strides in routine care. Pivotal to this advancement has been the incorporation and utilization of advanced neuroimaging, which has afforded stroke care providers a significant improvement in understanding of AIS pathophysiology and identification of its subclassifications toward better informed therapeutic decision making and resultant outcomes. As a consequence, acute stroke multimodal imaging methods are now recognized as an essential component of empirically based, best practice delivery of AIS care.
1,2 Furthermore, because of its now firmly established impact on and foothold within AIS management, advanced stroke imaging has positioned itself as a continued prime player in the field's ongoing goal to reduce barriers to treatment and facilitate success in outcomes.
In this review, we address the powerful ability of advanced acute stroke imaging to rapidly and accurately profile, understand, and characterize AIS pathophysiology, its crucial role in AIS routine practice currently, and the potential for its novel applications to continue to shape and advance the field of AIS in the future.
AIS has historically been classified into three distinct stages of cerebral hemodynamics. In stage I of an ischemic event, the cerebrovascular system labors to maintain a constant CBF in the face of low CPP through vasodilation of cerebral arterioles and recruitment of collateral cerebrovascular supply. At this stage, despite stress on the affected cerebrovascular territory, compromise and resultant ischemia of its supplied territory is avoided, theoretically, indefinitely. However, as the limits of autoregulation are reached and CBF nears the critical ischemic threshold, the cerebrovascular system enters stage II of AIS in which hemodynamic failure and increase of oxygen extraction occur. During this stage, the cerebral tissue is at risk of infarction, if reperfusion is not achieved promptly. This area of potentially salvageable tissue is termed the ischemic penumbra. With further reductions in CBF, failure of the collateral cerebrovascular supply follows, causing oxygen extraction to wane and become no longer sufficient to maintain tissue metabolism. Thus, irreversible injury and cell death (ischemic core) result.
Although AIS revascularization therapies have been well established to improve outcomes on a population basis, a significant proportion of patients treated within established timeframes of eligibility, unfortunately, do not reap significant functional improvement.
3 On a patient level, these effects are likely attenuated and/or negated because these time windows of symptom duration do not adequately account for variations in individual cerebrovascular anatomy, cerebral autoregulation reserve, and collateral cerebrovascular supply, and status. Cerebral collateral circulation helps stem expansion of infarct core volume via shunting the blood supply around an arterial occlusion through alternative arterial pathways, thereby maintaining adequate CBF to the affected field of tissue. Stroke severity and rate of ischemic injury progression are largely dependent upon a complex interplay between, among others, robustness of collateral circulation, the CBF nadir, and chronic disease states, such as chronic hypertension, which can shift the limits of autoregulation. 4 For example, for a given affected territory, a patient with low CBF and poor baseline collateral anatomy and/or status is likely to more quickly "complete"
conversion from penumbra to ischemic core than, for example, a patient with higher CBF and good baseline collateral anatomy and/or status.
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Present Applications of Acute Stroke Imaging
The goal of acute stroke imaging is to provide a rapid, accurate snapshot of acute brain and cerebrovascular pathology to determine which patients are most likely to be favorable candidates for and responders to revascularization therapies, such as intravenous (IV) tissue plasminogen activator (tPA) and endovascular revascularization therapies (ERTs). Brain imaging, traditionally and most commonly with noncontrast head CT, plays an essential role in AIS treatment selection and eligibility determination. For one, it is the only imaging modality required for determination of eligibility for IV tPA administration. Its main role is to exclude radiographic contraindications to IV tPA, namely, intracranial hemorrhage, large ischemic strokes (less than one-third of the middle cerebral artery [MCA] territory), and structural lesions such as tumors. 6, 7 Despite the fact that CT has low sensitivity (42-63%) for detection of acute and small ischemic infarcts, especially in the posterior fossa, 8 its rapid acquisition time, relative ease of identification of hemorrhage by nonradiologists, and widespread availability in the community make CT the recommended imaging modality in the time-sensitive evaluation for IV tPA.
7
Even though CT is the clear modality of choice in routine practice, MRI is utilized at some centers as the first-line brain imaging method. MR imaging holds a few key advantages over CT-based brain imaging in AIS care. For one, diffusionweighted imaging (DWI) offers superior sensitivity and specificity over CT in AIS detection. DWI abnormalities appear within minutes after ischemia occurs and may be detected in as many as 96.1 to 99.6% of patients when performed within 6 hours of the onset. 9 Moreover, through multiple different imaging sequences (fluid attenuated inversion recovery [FLAIR] , gradient echo [GRE] , and T2-weighted sequences),
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MRI provides more information about ischemia-associated lesions that CT cannot offer, including high resolution and accuracy of location and pattern, chronicity, and ischemic/ hemorrhagic components, all of which lend additional diagnostic power toward assessment and understanding of lesion etiology. While MRI can offer enhanced diagnostic power to the stroke care provider and thus improved ability to guide AIS treatment, it has a few important disadvantages (in comparison to noncontrast CT) that have limited its widespread adoption; mainly, its use is often considered more time and cost prohibitive. For one, MR facilities at most centers are not typically physically located near the emergency department (ED) triage area, thus delaying expedient completion. Additionally, costs associated with MR facility maintenance and operation often may prove unjustifiable for around-the-clock availability, especially in centers of care where MRI may not be commonly utilized, such as in rural communities or in areas of low-population density. Furthermore, unlike CT, MRI requires safety screening and patient consent, which may lend to additional impediments and delays to timely completion, especially in select AIS subpopulations (e.g., those with aphasia, neglect, or impaired consciousness). Lastly, although MRI holds greater diagnostic power than CT in AIS management, it requires greater knowledge and familiarity with a wider range of aforementioned imaging sequences, and thus its diagnostic application often necessitates input from radiologists. In addition to evaluating for such exclusions to tPA, like acute hemorrhage, brain imaging also enables stroke care providers to predict safety and efficacy of AIS treatment at the patient level. For one, early infarct core size holds key prognostic value for treatment decision making.
11 This has resulted in its increasingly more commonplace use in routine practice, including through incorporation of formal scoring metrics, such as the Alberta Stroke Program Early CT Score (ASPECTS). ASPECTS is an empirically validated, 10-point systematic method for evaluation of early ischemia within the anterior circulation on noncontrast brain CT (►Fig. 2). The parenchymal field subserved by the vascular territories of the anterior fossa is divided into 10 distinct regions, each of which is assessed and graded for early ischemic changes as defined by relative hypodensity. From this tabulation, a composite score from 10 (no ischemia) to 0 (ischemia of entire field) is generated that provides a rapid assessment of ischemic burden within the anterior vascular field, and consequently, prognosis for AIS treatment decision making through its identification of candidates most likely to respond clinically favorably (ASPECTS ! 6) to or to suffer complications from revascularization therapies. 1, 12 In addition to its well-established value in AIS care, another key advantage of ASPECTS is that it requires only basic familiarity with CT interpretation and the ASPECTS scoring methodology. Therefore, its powerful utility and ease of use encourage its readied adoption and use throughout the stroke care community at specialized and unspecialized centers alike.
In addition to providing critical information about status of parenchymal tissue, noncontrast brain CT also holds diagnostic utility in evaluation of vessel pathology in acute stroke care: the hyperdense thrombosed large-vessel sign. Visible as increased density, most classically in linear form for an affected proximal MCA vessel, the sign is highly suggestive of a largevessel occlusion (LVO) within the proper clinical context of an acute stroke syndrome attributable to occlusion of that vessel. This sign is seen in approximately only one-third of angiographically confirmed LVOs. 13, 14 Therefore, although its detection may provide guidance for treatment decision making, its absence does not permit such guidance. While brain imaging has been a mainstay of AIS care for over two decades, acute stroke multimodal imaging has materialized as a necessary component of routine care only in the past few years. The success of the multiple, recent ERT trials that relied on cerebrovascular angiographic imaging for determination of AIS treatment eligibility within expanded time windows legitimized the necessity and paved the way for this radical update of imaging used in routine care. Their landmark achievement firmly established that the incorporation of such imaging methods into AIS care provides not only a further enhanced profiling of acute stroke pathophysiology through rapid detection and assessment of thrombotic clot burden and location, 1 the presence of other vascular lesions (e.g., cerebral aneurysms, vascular malformations), and collateral vasculature status, but also, as a result, a powerful imaging-based strategy of management that enhances eligibility for therapy as well as prognosis.
The cerebrovascular imaging modality of choice is CT angiography (CTA) because of its wide availability, rapid acquisition time, and high sensitivity and specificity for LVO detection. 15 Of note, CTA carries a risk, although small and of unestablished significance, of contrast-related nephropathy, [16] [17] [18] particularly among patients with pre-existing impairment of renal function. Magnetic resonance angiography (MRA) is another choice used as a first-line option at some centers; it has lower sensitivity but comparable specificity to CTA. 15 Common MRA techniques include two-dimensional time of flight (TOF), three-dimensional TOF, and gadolinium-enhanced MRA. The gadoliniumenhanced technique allows improved visualization of distal vessels and is less susceptible to motion artifacts. The nonenhanced TOF, though more susceptible to motion artifact, may be preferred in patients with baseline kidney disease who are at risk for complications related to gadolinium exposure, including, most seriously, nephrogenic systemic fibrosis. While TOF MRA is helpful in identifying proximal LVOs, it is not considered as reliable for detection of distal vessel occlusions.
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The 2015 update of the American Heart Association (AHA)/ American Stroke Association (ASA) guidelines reflects the advent of advanced imaging as standard of care when considering endovascular treatment options for patients with AIS.
1 Multimodal imaging, in the form of ASPECTS, as well as evidence of large vessel occlusion on CT angiogram, was a critical feature leading to the overall success of the endovascular trials (►Table 1). Despite some variation in selection criteria for the different trials, mainly regarding the minimum eligible National Institutes of Health Stroke scale (NIHSS) score and also the timeframe for inclusion, the use of more refined imaging tactics allowed for improved selection of patients who were more likely to have a beneficial response to endovascular intervention. The available data from the aforementioned studies led to the recommendation that endovascular intervention should be considered for patients who present with NIHSS and ASPECTS greater than 6 and an imaging-confirmed internal carotid artery (ICA) or MCA large-vessel (M1) occlusion within 6 hours from symptom onset.
In the wake of these recent advances and the AHA/ASA recommendations that were based upon them, treatment centers have begun to update their acute stroke imaging protocols to reflect these new standards in stroke care. As an illustrative example, a typical acute stroke imaging pathway for patients presenting to a comprehensive stroke center, with stroke symptoms suggestive of a LVO syndrome within 6 hours, is presented in ►Fig. 4 and ►Fig. 5.
Future Applications of Acute Stroke Imaging
The currently accepted model of AIS considers both the ischemic core and penumbra of an affected vascular territory as essential to the profile of AIS in vivo. Because it is at risk, but still viable tissue, the penumbra is the prime target of salvage for all revascularization therapies. 20 Perfusion imaging modalities (CT and MR perfusion) allow estimation of penumbral volume through assessment of cerebral hemodynamics by tracking the flow of contrast within a region of interest and generating qualitatively informative maps for CBF, cerebral blood volume (CBV), mean transit time (MTT), and time to peak (TTP). These maps may, in turn, be used to estimate the volume of the ischemic core and ischemic penumbra (►Table 2). Not surprisingly, because of its unique capability to provide penumbral status in AIS, perfusion-based imaging is considered to hold great potential in the continued advancement of AIS care. Integration of such advanced imaging methods into acute stroke imaging further refines the profile of AIS through an assessment that reflects, within an affected cerebrovascular territory, not only ischemic status (e.g., ASPECTS of noncontrast head CT) and thus infarcted tissue, which reduces candidacy for treatment, but also of penumbral status and thus tissue, which may respond best to it. As a result, perfusionbased acute stroke imaging theoretically allows the provider to depend less strictly, in absolute terms, on time/duration of symptoms: a potential key to further reduce time-based restrictions to improve outcomes from treatments. 21 Although not yet evidence based, some stroke centers have already incorporated perfusion imaging into their acute stroke imaging protocol and may employ such a hypothetical pathway for Abbreviations: CTA, computed tomography angiography; DSA, digital subtraction angiography; DWI, diffusion-weighted imaging; ICA, internal carotid artery; MRA, magnetic resonance angiography. a Modified Rankin Score (0-2) at 90 days, treatment versus control groups. b Perfusion assessed with an automated reading software (RAPID). Hypoperfusion was defined as T max > 6 seconds. Ischemic core diagnosed as relatively CBF < 30% of normal tissue or by DWI volume. c Infarct less than one-third of the MCA territory on CT or DWI, or > 100 mL in other territories. Severe hypoperfusion (T max > 10 second) < 100 mL. d Moderate-to-good collateral circulation was defined as the filling of 50% or more of the MCA by pial arterial circulation on CTA.
identifying AIS candidates for treatment who present beyond 6 hours from symptom onset (►Fig. 5).
In line with this rationale of use by some centers, the ability to translate perfusion-based imaging's unique assessment of salvageable tissue status into improved outcomes is currently under investigation.
22 Studies using perfusion-based techniques have already provided demonstration that profiles reflecting a small infarct core to large penumbra ratio are considered most likely to respond favorably to reperfusion therapies.
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The concept of perfusion-guided intervention in extended time windows is currently under investigation for both IV tPA and ERT (►Fig. 6 and ►Table 3). Both the European cooperative acute stroke study-4: Extending the time for thrombolysis in emergency neurological deficits (ECASS:4 ExTEND) 25 and the multicenter, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND) 26 trials are testing the utility of perfusion imaging for an extended time window for IV tPA (up to 9 hours). Because it has been shown that ischemic penumbra may be present up to 24 hours in AIS, 27 great interest has focused on expanding allowed time windows of treatment even further: the Endovascular therapy following imaging evaluation for ischemic stroke 3 (DEFUSE 3), 22 Perfu- 
Abbreviations: CBF, cerebral blood flow; CBV, cerebral blood volume; CT, computed tomography; MTT, mean transit time. perfusion-based techniques for treatment up to 24 hours after symptom onset. Although inclusion criteria and perfusion parameters vary between these trials, a priori requisite assessment of a favorable penumbra/core volume ratio for determination of treatment candidacy is shared by all of them.
Although of currently unknown clinical utility, arterial spin labeled (ASL)-MRI is another emerging perfusion imaging method, which holds exciting implications for potential application in AIS. 2, 30 This technique assesses diffusion of arterial water to generate a CBF map, and thus estimate ischemic penumbra. A major advantage of ASL is that it requires no IV contrast, which makes its validation highly attractive as an imaging application that may enhance care without compromise of safety (►Fig. 7).
As AIS investigations utilizing perfusion-based imaging continue to improve understanding of the ischemic penumbra and its relationship with and transition to the ischemic core, an improved and more accurate profiling of the AIS pathophysiology will hopefully follow toward achievement of ultimate goal of the stroke community: care freed from the restrictions of time and that optimizes chances for best outcomes.
Transition from CT to MR Acute Stroke Imaging
Although CT-based imaging has been the cornerstone of advanced imaging within acute stroke and its improvement in care, MR-based methods provide even greater promise for potential advances in AIS care. Not only are their sensitivity and specificity for detection of ischemia superior to CTbased methods, 9 but also MR-based methods are acquired in equitably rapid fashion 31 with reduced risk exposure.
Hence, utilization of MR-based acute stroke imaging may prove to further AIS care in a variety of ways: refining diagnosis and thus increasing treatment rates, as well as mitigating unnecessary imaging and treatment exposure. For instance, implementation of rapid MRI 31 protocols in routine AIS care may better identify ischemic events masquerading as nonischemic ones and exclude nonischemic ones mimicking ischemic ones.
Conclusion
Advanced stroke imaging has established itself as an integral component of AIS practice. Multimodal imaging methods afford an enriched understanding of acute stroke pathophysiology that empowers providers to deliver stroke care that reflects standards of care aimed at achievement of best outcomes. Advanced stroke imaging is likely to continue to be a driver of the ever-evolving field of AIS: one highlighted by less barriers to, and more successes from, treatment. 
